4.7 Article

Standardised survival probabilities: a useful and informative tool for reporting regression models for survival data

Journal

BRITISH JOURNAL OF CANCER
Volume 127, Issue 10, Pages 1808-1815

Publisher

SPRINGERNATURE
DOI: 10.1038/s41416-022-01949-6

Keywords

-

Categories

Funding

  1. Swedish Cancer Society [19 0102]
  2. Swedish Research Council [2019-01965, 2019-00227]
  3. Strategic Research Area in Epidemiology and Biostatistics (SFOepi) at Karolinska Institutet
  4. Region Stockholm
  5. Swedish Cancer Society (Cancerfonden) [2018/744]
  6. Swedish Research Council (Vetenskapsradet) [2017-01591]
  7. Karolinska Institute
  8. Swedish Research Council [2019-01965, 2017-01591] Funding Source: Swedish Research Council

Ask authors/readers for more resources

This study discusses the feasibility of using standardized survival probabilities to report treatment effects while adjusting for confounding, and highlights the importance of this method in interpreting risks.
Background When interested in studying the effect of a treatment (or other exposure) on a time-to-event outcome, the most popular approach is to estimate survival probabilities using the Kaplan-Meier estimator. In the presence of confounding, regression models are fitted, and results are often summarised as hazard ratios. However, despite their broad use, hazard ratios are frequently misinterpreted as relative risks instead of relative rates. Methods We discuss measures for summarising the analysis from a regression model that overcome some of the limitations associated with hazard ratios. Such measures are the standardised survival probabilities for treated and untreated: survival probabilities if everyone in the population received treatment and if everyone did not. The difference between treatment arms can be calculated to provide a measure for the treatment effect. Results Using publicly available data on breast cancer, we demonstrated the usefulness of standardised survival probabilities for comparing the experience between treated and untreated after adjusting for confounding. We also showed that additional important research questions can be addressed by standardising among subgroups of the total population. Discussion Standardised survival probabilities are a useful way to report the treatment effect while adjusting for confounding and have an informative interpretation in terms of risk.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Five ways to improve international comparisons of cancer survival: lessons learned from ICBP SURVMARK-2

Therese M. -L. Andersson, Tor Age Myklebust, Mark J. Rutherford, Bjorn Moller, Melina Arnold, Isabelle Soerjomataram, Freddie Bray, D. Maxwell Parkin, Paul C. Lambert

Summary: This study examines the comparison of population-based cancer survival rates internationally and aims to improve the harmonization of cancer registry datasets for future benchmarking exercises. It emphasizes the importance of understanding and addressing international variations in outcomes among cancer patients.

BRITISH JOURNAL OF CANCER (2022)

Article Oncology

A way to explore the existence of immortals in cancer registry data - An illustration using data from ICBP SURVMARK-2

Therese M. -L. Andersson, Mark J. Rutherford, Tor Age Myklebust, Bjorn Moller, Melina Arnold, Isabelle Soerjomataram, Freddie Bray, Hazem Abd Elkader, Gerda Engholm, Dyfed Huws, Alana Little, Lorraine Shack, Paul M. Walsh, Ryan R. Woods, D. Maxwell Parkin, Paul C. Lambert

Summary: The study found that, except in Ireland, there were few long-term survivors in the early years of the ICBP SURVMARK-2 project. This finding is important for accurately estimating cancer patient survival.

CANCER EPIDEMIOLOGY (2022)

Article Health Care Sciences & Services

Assessing the impact of including variation in general population mortality on standard errors of relative survival and loss in life expectancy

Yuliya Leontyeva, Hannah Bower, Oskar Gauffin, Paul C. Lambert, Therese M-L Andersson

Summary: Ignoring uncertainty in general population mortality rates has negligible impact on the SEs of 5-year RS and LLE when based on the whole population, but can have a larger impact when based on a smaller population for expected mortality rates estimation, particularly for marginal values.

BMC MEDICAL RESEARCH METHODOLOGY (2022)

Article Oncology

Quantifying Differences in Remaining Life Expectancy after Cancer Diagnosis, Aboriginal and Torres Strait Islanders, and Other Australians, 2005-2016

Paramita Dasgupta, Therese M-L Andersson, Gail Garvey, Peter D. Baade

Summary: There are differences in remaining life expectancy (RLE) among Aboriginal and Torres Strait Islander and other Australian patients with cancer, partly due to disparities in cancer and noncancer mortality. If the cancer survival disparities were removed, Aboriginal and Torres Strait Islanders diagnosed with cancer could gain more population life years.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2022)

Article Statistics & Probability

Potential bias introduced by not including multiple time-scales in survival analysis: a simulation study

Nurgul Batyrbekova, Hannah Bower, Paul W. Dickman, Robert Szulkin, Paul C. Lambert, Therese M. -L. Andersson

Summary: When analyzing cohort data, it is common to only consider one time-scale and include other time-scales as fixed covariates. This simulation study demonstrates that only modeling one time-scale can lead to biased estimates of survival proportions and hazard ratios, especially when there are non-proportional hazards on the second time-scale. Including non-proportional hazards and interactions with the time-scale is advisable when modeling only one time-scale.

COMMUNICATIONS IN STATISTICS-SIMULATION AND COMPUTATION (2022)

Article Oncology

Health Anxiety and Its Relationship to Thyroid-Hormone-Suppression Therapy in Patients with Differentiated Thyroid Cancer

Maximilian Zoltek, Therese M-L Andersson, Erland Axelsson, Christel Hedman, Catharina Ihre Lundgren

Summary: This study investigated the relationship between health anxiety and TSH-suppression treatment in patients with differentiated thyroid cancer (DTC). The results showed that health anxiety appears to be slightly higher among DTC patients compared to the general population, but it is not clearly connected to the TSH-suppression treatment.

CANCERS (2022)

Article Mathematical & Computational Biology

On the choice of timescale for other cause mortality in a competing risk setting using flexible parametric survival models

Nikolaos Skourlis, Michael J. Crowther, Therese M-L Andersson, Paul C. Lambert

Summary: In competing risks settings, using time since diagnosis as the timescale reduces bias in the cumulative incidence functions for cancer mortality and other cause mortality. However, using attained age as the timescale when modeling other cause mortality allows for more natural modeling.

BIOMETRICAL JOURNAL (2022)

Article Hematology

Sex differences in lymphoma incidence and mortality by subtype: A population-based study

Cecilia Radkiewicz, Johanna B. Bruchfeld, Caroline E. Weibull, Mathias L. Jeppesen, Henrik Frederiksen, Mats Lambe, Lasse Jakobsen, Tarec C. El-Galaly, Karin E. Smedby, Tove Wasterlid

Summary: It is well established that males have a higher risk and poorer survival of most cancers, and this pattern also applies to lymphomas. In this study, researchers used the Swedish Lymphoma Register to investigate sex differences in lymphoma subtype incidence and excess mortality. The findings showed that men had a significantly higher incidence and trend toward higher mortality in most lymphoma subtypes.

AMERICAN JOURNAL OF HEMATOLOGY (2023)

Article Health Care Sciences & Services

Modelling multiple time-scales with flexible parametric survival models

Nurgul Batyrbekova, Hannah Bower, Paul W. Dickman, Anna Ravn Landtblom, Malin Hultcrantz, Robert Szulkin, Paul C. Lambert, Therese M-L. Andersson

Summary: This study introduces a method to model multiple time-scales in survival analysis, avoiding data splitting, saving time, and reducing the likelihood of errors.

BMC MEDICAL RESEARCH METHODOLOGY (2022)

Article Dermatology

Association of metformin use and survival in patients with cutaneous melanoma and diabetes

Isabelle Krakowski, Henrike Habel, Kari Nielsen, Christian Ingvar, Therese M. L. Andersson, Ada Girnita, Karin E. Smedby, Hanna Eriksson

Summary: This study investigated the association between metformin use and survival in diabetic patients with cutaneous melanoma. The results showed that metformin use was associated with improved overall survival regardless of timing and followed a dose-response pattern. However, no association was found between metformin use and melanoma-specific survival.

BRITISH JOURNAL OF DERMATOLOGY (2023)

Article Oncology

Seasonal effects on cancer incidence and prognosis

Ida Wiken, Therese M-L Andersson, Cecilia Radkiewicz

Summary: This study investigates the impact of holidays on cancer incidence and survival rates in Sweden. It finds that cancer cases decline during holidays and increase post-holidays for certain types of cancer. The study also reveals higher mortality rates for cancers diagnosed during holidays, emphasizing the need for consistent cancer care throughout the year.

ACTA ONCOLOGICA (2023)

Article Health Care Sciences & Services

Exploring different research questions via complex multi-state models when using registry-based repeated prescriptions of antidepressants in women with breast cancer and a matched population comparison group

Nikolaos Skourlis, Michael J. Crowther, Therese M-L. Andersson, Donghao Lu, Mats Lambe, Paul C. Lambert

Summary: This study uses multi-state models to explore different research questions and modelling choices in the analysis of repeated prescriptions data. The results show that more complex multi-state structures can effectively capture the intermittent nature of medication use.

BMC MEDICAL RESEARCH METHODOLOGY (2023)

Article Oncology

Reranking cancer mortality using years of life lost

Cecilia Radkiewicz, Therese M-L Andersson, Jesper Lagergren

Summary: This study calculated years of life lost (YLL) due to the top 10 solid tumors causing the most deaths, using data from the Swedish National Cancer and Cause of Death Registers. The results showed that lung and colorectal cancer remained the leading causes of YLL, while pancreatic and breast cancer moved up in rank. Prostate cancer, on the other hand, moved down in rank. Women consistently lost more life years due to lung and pancreatic cancer, and the decline in colorectal cancer mortality was only reflected as a YLL decline in women. YLL is a simple and intuitive measure that expands our understanding of the cancer burden on society.

JNCI CANCER SPECTRUM (2023)

Article Oncology

Improving communication of cancer survival statistics-feasibility of implementing model-based algorithms in routine publications

Tor Age Myklebust, Bjarte Aagnes, Yngvar Nilssen, Mark Rutherford, Paul C. Lambert, Therese M. L. Andersson, Anna L. V. Johansson, Paul W. Dickman, Bjorn Moller

Summary: Background: Routine reporting of cancer patient survival is vital for monitoring healthcare effectiveness and prognosis. Objective: This study aims to explore the feasibility of automating the production of these statistics. Results: We obtained reliable estimates of survival rates for most cancer types. Discussion: Implementing new survival measures in routine publications may be challenging, but we propose a method for automating the production of these statistics.

BRITISH JOURNAL OF CANCER (2023)

No Data Available